NOD1 and hepatocellular carcinoma: The overexpression of NOD1 significantly inhibited carcinogenesis in vivo and increased the sensitivity of hepatocellular carcinoma cells to chemotherapy via blocking the mitogen-activated protein kinase (MAPK) pathway (Ma, et al., 2020).